18F-FDGPET/CT: Diabetes and hyperglycaemia

Nuclear Medicine Review

Volumn 16, Issue 2, 2013, Pages 57-61

  Niccoli Asabella, Artor ^a   Iuele, Francesca ^a   Merenda, Nunzio ^a   Pisani, Antonio Rosario ^a   Notaristefano, Antonio ^a   Rubini, Giuseppe ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

18F FDG PET CT; Diabetes; EANM guidelines; Hyperglycaemia; Insulin; Preparation protocols; Snm guidelines

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; INSULIN; ORAL ANTIDIABETIC AGENT;

ARTICLE; CLINICAL EVALUATION; CLINICAL PROTOCOL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIABETIC PATIENT; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MEDICAL DEVICE; MEDICAL HISTORY; MEDICAL SOCIETY; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PET-CT SCANNER; PRACTICE GUIDELINE; SCREENING;

DIABETES COMPLICATIONS; FLUORODEOXYGLUCOSE F18; HUMANS; HYPERGLYCEMIA; LUNG NEOPLASMS; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84890867056     PISSN: 15069680     EISSN: None     Source Type: Journal    
DOI: 10.5603/NMR.2013.0035     Document Type: Article

References (29)

1. Hahn T, Hofmann W, Reich O, Lang I, Desoye G. Hyperglycaemia regulates the glucose-transport system of clonal choriocarcinoma cells in vitro. A potential molecular mechanism contributing to the adjunct of glucose in tumour therapy. Int J Cancer 1998; 78: 353-360.
2. White MK, McCubrey JA. Changes in glucose transport associated with malignant transformation. Int J Oncol 1995; 7: 701-712.
3. Diederichs CG, Staib L, Glatting G, Beger HG, Reske SN. FDG-PET: elevated plasma glucose reduces both uptake and detection rate of pancreatic malignancies. J Nucl Med 1998; 39: 1030-1033.
4. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012 Jan 35(suppl 1): S64-S71.
5. Clement S, Braithwaite SS, Magee MF et al. American Diabetes Association Diabetes in Hospital Writing Committee. Management of Diabetes and Hyperglycaemia in Hospitals. Diabetes Care 2004 Feb; 27(2): 553-91
6. Niccoli Asabella A, Notaristefano A, Pisani AR, Iuele F, Altini C, Rubini G. Different causes of 18-Fluorine-labelled-2-deoxy-2-fluoro-D-glucose uptake in a patient with non-Hodgkin lymphoma Gazzetta Medica Italiana Archivio per le Scienze Mediche 2012; 171: 351-356.
7. Ciccone MM, Niccoli-Asabella A, Scicchitano P et al. Cardiovascular risk evaluation and prevalence of silent myocardial ischemia in subjects with asymptomatic carotid artery disease. Vasc Health Risk Manag 2011; 7: 129-134.
8. Niccoli-Asabella A, Ferlan G, Crovace A et al. Swine experimental model to evaluate stem cells implant post myocardial infarction by perfusion gated-SPET. Hell J Nucl Med 2012; 15: 16-22.
9. Lindholm P, Minn H, Leskinen-Kallio S, Bergman J, Ruotsalainem U, Joensuu H. Influence of the blood glucose concentration on FDG uptake in cancer - a PET study. J Nucl Med 1993; 34: 1-6.
10. Delbeke D, Coleman RE, Guiberteau MJ et al. Procedure guideline for tumour imaging with 18F-FDG PET/CT 1.0. J Nucl Med 2006;47: 885-895.
11. Bombardieri E, Aktolun C, Baum RP et al. FDG-PET: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging 2003; 30: BP115-BP124.
12. Boellaard R, O'Doherty MJ, Weber WA et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging 2010; 37: 181-200.
13. Torizuka T, Zasadny KR, Wahl RL. Diabetes decreases FDG accumulation in primary lung cancer. Clin Positron Imaging 1999; 2: 281-287.
14. Gorenberg M, Hallett WA, O'Doherty MJ. Does diabetes affect [18F]FDG standardized uptake values in lung cancer? Eur J Nuc Med 2002; 29: 1324-1327.
15. Wahl RL, Henry CA, Eithier SP. Serum glucose: effects on tumour and normal tissue accumulation of 2-(F-18)-fluoro-2-deoxy-D-glucose in rodents with mammary carcinoma. Radiology 1992; 183: 643-647.
16. Zhuang HD, Cortes-Blanco A, Pourdehnad M. Do high glucose levels have differential effect on FDG uptake in inflammatory and malignant disorders. Nucl Med Commun 2001; 22: 1123-1128.
17. Langen KJ, Braun U, Rota Kops E et al. The influence of plasma glucose levels on fluorine-18-fluorodeoxyglucose uptake in bronchial carcinomas. J Nucl Med 1993; 34: 355-359.
18. Torizuka T, Zasadny KR, Wahl RL. Diabetes decreases FDG accumulation in primary lung cancer. Clin Positron Imaging 1999; 2: 281-287.
19. Chang YC, Yen TC, Ng KK et al. Does diabetes mellitus influence the efficacy of FDG-PET in the diagnosis of cervical cancer? Eur J Nucl Med Mol Imag 2005; 32: 1324-1327.
20. Torizuka T, Fisher SJ, Brown RS, Wahl RL. Effect of insulin on uptake of FDG by experimental mammary carcinoma in diabetic rats. Radiology 1998; 208: 499-504.
21. Turcotte E, Leblanc M, Carpentier A, Bénard F. Optimizatio of whole-body positron emission tomography imagin by using delayed 2-deoxy-2-[F-18] fluoro-D-glucose injection following I.v. Insulin in diabetic patients. Mol Imaging Biol 2006; 8: 348-354.
22. Roy FN, Beaulier S, Boucher L, Bourdeau I, Cohade C. Impact of intravenous insulin on 18F-FDG PET in diabetic cancer patients. J Nucl Med 2009; 50: 178-183.
23. DeFronzo RA, Barilai N, Simonson DC. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects. J Clin Endocrinol Metab 1991; 73: 1294-1301.
24. Dasgeb B, Siegel E. Alteration of FDG uptake associated with metformin: pitfall and opportunity. J Nucl Med. 2007; 48: 184P.
25. Gontier E, Fourme E, Wartski M et al. High and typical 18F-FDG bowel uptake in patients treated with metformin. Eur J Nucl Med Mol Imaging 2008; 35: 95-99.
26. Akhurst T, Boland P, Macapinlac H et al. Excess muscle FDG uptake in a euglycaemic patient that is corrected by fasting. Clin Pos Imaging 1998; 1: 131-133.
27. Minn H, Nuutila P, Lindholm P et al. In vivo effects of insulin on tumour and skeletal muscle glucose metabolism in patients with lymphoma. Cancer 1994; 73: 1490-1498.
28. Hamblen SM, Lowe VJ. Clinical 18F-FDG oncology patient preparation techniques. J Nucl Med Technol 2003; 31: 3-10.
29. Lin E. C., Alavi A. PET and PET/CT A Clinical Guide. Thieme Medical Publishers 2009.